BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25131213)

  • 1. Reconsidering the age thresholds for type II diabetes screening in the U.S.
    Chung S; Azar KM; Baek M; Lauderdale DS; Palaniappan LP
    Am J Prev Med; 2014 Oct; 47(4):375-81. PubMed ID: 25131213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.
    Klein Woolthuis EP; de Grauw WJ; van Gerwen WH; van den Hoogen HJ; van de Lisdonk EH; Metsemakers JF; van Weel C
    Ann Fam Med; 2009; 7(5):422-30. PubMed ID: 19752470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of different screening strategies for type 2 diabete on preventing cardiovascular diseases in a community-based Chinese population using a decision-analytic Markov model].
    Wang JM; Liu QP; Zhang ML; Gong C; Liu SD; Chen WY; Shen P; Lin HB; Gao P; Tang X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):450-457. PubMed ID: 35701121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the U.S. Preventive Services Task Force criteria for diabetes screening.
    Casagrande SS; Cowie CC; Fradkin JE
    Am J Prev Med; 2013 Aug; 45(2):167-74. PubMed ID: 23867023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes.
    Bowen ME; Xuan L; Lingvay I; Halm EA
    Am J Prev Med; 2017 Jun; 52(6):710-716. PubMed ID: 28279547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the new guidelines on an earlier age threshold of 35 years for diabetes screening can identify an additional 6.3 million undiagnosed individuals with diabetes and 72.3 million individuals with prediabetes among Chinese adults: An analysis of a nationally representative survey.
    Cao Q; Zheng R; He R; Wang T; Xu M; Lu J; Dai M; Zhang D; Chen Y; Zhao Z; Wang S; Lin H; Wang W; Ning G; Bi Y; Xu Y; Li M
    Metabolism; 2022 Sep; 134():155238. PubMed ID: 35697298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes.
    O'Brien MJ; Bullard KM; Zhang Y; Gregg EW; Carnethon MR; Kandula NR; Ackermann RT
    J Gen Intern Med; 2018 Jul; 33(7):1100-1108. PubMed ID: 29651678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines.
    Dall TM; Narayan KM; Gillespie KB; Gallo PD; Blanchard TD; Solcan M; O'Grady M; Quick WW
    Popul Health Metr; 2014; 12():12. PubMed ID: 24904239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to improve opportunistic screening by using EMRs and other data. The prevalence of undetected diabetes mellitus in target population in Croatia.
    Vrca Botica M; Carkaxhiu L; Kern J; Pavlić Renar I; Botica I; Zelić I; Iliev D; Vrca A
    Public Health; 2017 Apr; 145():30-38. PubMed ID: 28359387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and determinants of screening for diabetes in the U.S.
    Cowie CC; Harris MI; Eberhardt MS
    Diabetes Care; 1994 Oct; 17(10):1158-63. PubMed ID: 7821136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of guidelines for screening diabetes mellitus in an ambulatory population.
    Sheehy AM; Flood GE; Tuan WJ; Liou JI; Coursin DB; Smith MA
    Mayo Clin Proc; 2010 Jan; 85(1):27-35. PubMed ID: 20042558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
    O'Brien MJ; Lee JY; Carnethon MR; Ackermann RT; Vargas MC; Hamilton A; Mohanty N; Rittner SS; Park JN; Hassan A; Buchanan DR; Liu L; Feinglass J
    PLoS Med; 2016 Jul; 13(7):e1002074. PubMed ID: 27403739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for diabetes in India should be initiated at 25 years age.
    Misra A; Ramachandran A; Saboo B; Kesavadev J; Sosale A; Joshi S; Das AK
    Diabetes Metab Syndr; 2021; 15(6):102321. PubMed ID: 34739907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The USPSTF Recommends Earlier Screening for Prediabetes and Type 2 Diabetes.
    Todd B
    Am J Nurs; 2021 Dec; 121(12):60. PubMed ID: 34792510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening strategy for type 2 diabetes in the United Arab Emirates.
    Saadi H; Nagelkerke N; Al-Kaabi J; Afandi B; Al-Maskari F; Kazam E
    Asia Pac J Public Health; 2010 Jul; 22(3 Suppl):54S-59S. PubMed ID: 20566534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study.
    Keipes M; Bellucci A; Hansen E
    Bull Soc Sci Med Grand Duche Luxemb; 2012; (2):25-35. PubMed ID: 23362564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported prevalence of diabetes screening in the U.S., 2005-2010.
    Casagrande SS; Cowie CC; Genuth SM
    Am J Prev Med; 2014 Dec; 47(6):780-7. PubMed ID: 25241199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines.
    Janssen I; Katzmarzyk PT; Ross R
    Arch Intern Med; 2002 Oct; 162(18):2074-9. PubMed ID: 12374515
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.